13-99536684-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004800.3(TM9SF2):āc.538A>Gā(p.Ile180Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000821 in 1,461,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004800.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TM9SF2 | NM_004800.3 | c.538A>G | p.Ile180Val | missense_variant | 5/17 | ENST00000376387.5 | NP_004791.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TM9SF2 | ENST00000376387.5 | c.538A>G | p.Ile180Val | missense_variant | 5/17 | 1 | NM_004800.3 | ENSP00000365567.3 | ||
TM9SF2 | ENST00000642475.1 | c.538A>G | p.Ile180Val | missense_variant | 7/19 | ENSP00000493515.1 | ||||
TM9SF2 | ENST00000463709.1 | n.550A>G | non_coding_transcript_exon_variant | 6/7 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251362Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135858
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461476Hom.: 0 Cov.: 30 AF XY: 0.00000825 AC XY: 6AN XY: 727050
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.538A>G (p.I180V) alteration is located in exon 5 (coding exon 5) of the TM9SF2 gene. This alteration results from a A to G substitution at nucleotide position 538, causing the isoleucine (I) at amino acid position 180 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at